Re: Roddam AW, Duffy MJ, Hamdy FC, et al. Use of prostate-specific antigen (PSA) isoforms for the detection of prostate cancer in men with a PSA Level of 2-10 ng/ml: systematic review and meta-analysis. Eur Urol 2005;48:386-99.

Re: Roddam AW, Duffy MJ, Hamdy FC, et al. Use of prostate-specific antigen (PSA) isoforms for the detection of prostate cancer in men with a PSA Level of 2-10 ng/ml: systematic review and meta-analysis. Eur Urol 2005;48:386-99.

Bibliografske podrobnosti
Main Authors:	Stephan, C, Schnorr, D, Loening, SA, Jung, K
Format:	Journal article
Jezik:	English
Izdano:	2005

Podobne knjige/članki

Re: Roddam AW, Duffy MJ, Hamdy FC, et al. Use of prostate-specific antigen (PSA) isoforms for the detection of prostate cancer in men with a PSA level of 2-10 ng/ml: Systematic review and meta-analysis. Eur Urol 2005;48 : 386-99 - Reply to C. Stephan, D. Schnorr, S.A. Loening, K. Jung
od: Roddam, A, et al.
Izdano: (2005)

Zonal adjusted PSA density improves prostate cancer detection rates compared with PSA in Taiwanese males with PSA < 20 ng/ml
od: Tsung-Hsin Chang, et al.
Izdano: (2020-10-01)

Association of Obesity and Smoking With PSA and PSA Velocity in Men With Prostate Cancer
od: Amit M. Algotar PhD, MBBS, et al.
Izdano: (2011-05-01)

Comparison between PSA density, free PSA percentage and PSA density in the transition zone in the detection of prostate cancer in patients with serum PSA between 4 and 10 ng/ml
od: Emerson P. Gregorio, et al.
Izdano: (2007-04-01)

Variation in percentage-free prostate-specific antigen (PSA) with prostate volume, age and total PSA level.
od: Törnblom, M, et al.
Izdano: (2001)

Relation between Serum Level of Total PSA and Free PSA/Total PSA Ratio with Grade of Prostate Cancer
od: Mohammad Yazdani, et al.
Izdano: (2013-10-01)

Association between polymorphisms in the prostate-specific antigen (PSA) promoter and release of PSA.
od: Sävblom, C, et al.
Izdano: (2009)

CUT-OFF POINT OF PSA AND PSA DENSITY IN PROSTATE CANCER SUSPECTED PATIENTS
od: Daniel Simanjuntak, et al.
Izdano: (2016-03-01)

Utility of PSA isoform-[-2] proPSA (p2PSA) and prostate health index in the diagnosis of prostate cancer: A study in Indian population
od: Govinda Raju NL, et al.
Izdano: (2022-01-01)

Accuracy assessment of PSA methods must be based on clinical instead of artificial samples - a response to AW Roddam et al., Ann Clin Biochem 2006;43 : 35-48 - Reply
od: Roddam, A, et al.
Izdano: (2006)

Free PSA and prostate volume on the diagnosis of prostate carcinoma
od: Antonio Carlos Pereira Martins, et al.
Izdano: (2003-01-01)

Blood levels of free-PSA but not complex-PSA significantly correlates to prostate release of PSA in semen in young men, while blood levels of complex-PSA, but not free-PSA increase with age.
od: Sävblom, C, et al.
Izdano: (2005)

Quality assessment for prostate-specific antigen (PSA) in relation to ERSPC: report of the PSA committee.
od: Blijenberg, BG, et al.
Izdano: (2003)

Detection of prostate cancer with complexed PSA and complexed/total PSA ratio - is there any advantage?
od: Strittmatter F, et al.
Izdano: (2011-10-01)

Age-specific reference intervals for Prostate-Specific-Antigen (PSA), its isoform-[-2] pro-PSA (p2PSA) and prostate health index in Indian males
od: Govinda Raju NL, et al.
Izdano: (2024-04-01)

Free PSA performs better than total PSA in predicting prostate volume in Chinese men with PSA levels of 2.5–9.9 ng ml−1
od: Ma-Ping Huang, et al.
Izdano: (2023-01-01)

Prostate cancer: estimating the benefits of PSA screening.
od: Vickers, A, et al.
Izdano: (2009)

Prostate cancer recurrence in the urethra with low PSA
od: Shravankrishna Ananthapadmanabhan, et al.
Izdano: (2024-07-01)

Prostate Specific Antigen (PSA): The Historical Perspective
od: T. Ming Chu
Izdano: (2020-12-01)

Histomorphologic Correlation of PSA Levels in Prostatic Pathology
od: Deepak Panasseril Jayapradeep, et al.
Izdano: (2017-10-01)

Prospective validation of %p2PSA and the Prostate Health Index, in prostate cancer detection in initial prostate biopsies of Asian men, with total PSA 4-10 ng ml-1
od: Lincoln GL Tan, et al.
Izdano: (2017-01-01)

Optimal PSA density threshold for prostate biopsy in benign prostatic obstruction patients with elevated PSA levels but negative MRI findings
od: Yiji Peng, et al.
Izdano: (2025-03-01)

Diagnostic value of free-to-total PSA proportion and PSA density in prostate cancer detection for prostate volumes >= 100 cc
od: Murat Zor, et al.
Izdano: (2018-12-01)

Association of serum prostate-specific antigen (PSA) level and circulating tumor cell-based PSA mRNA in prostate cancer
od: Hyungseok Cho, et al.
Izdano: (2022-03-01)

Use of prostate-specific antigen (PSA) isoforms for the detection of prostate cancer in men with a PSA level of 2-10 ng/ml: systematic review and meta-analysis.
od: Roddam, A, et al.
Izdano: (2005)

Uji diagnostik prostate spesific antigen (PSA) pada keganasan prostat
od: , DAHESIHDEWI, Andaru, et al.
Izdano: (2002)

Malakoplakia of the prostate diagnosed by elevated PSA level and transrectal prostate biopsy
od: Sacit Nuri Görgel, et al.
Izdano: (2011-04-01)

Role of Prostate-Specific Antigen (PSA) in Patients with Benign Prostate Hyperplasia
od: Priya Duvedi, et al.
Izdano: (2019-05-01)

Predictors of Clinically Significant Prostate Cancer: A Comparative Study of PSA, PSA Density, and MRI Parameters
od: Mehmet Coşkun, et al.
Izdano: (2021-02-01)

AGE, TOTAL PSA, PSA DENSITY AND GLEASON SCORE, TAUS AS PREDICTIVE FACTORS IN PATIENTS WITH PROSTATE CANCER
od: Daruqutni Albar, et al.
Izdano: (2016-03-01)

Incidence of histological prostatitis and its correlation with PSA density
od: Affonso Celso Piovesan, et al.
Izdano: (2009-11-01)

Metastatic prostate cancer in the modern era of PSA screening
od: Philip A. Fontenot Jr, et al.

PSA testing for men at average risk of prostate cancer
od: Bruce K Armstrong, et al.
Izdano: (2017-07-01)

THE INCIDENCE AND CORRELATION OF CHRONIC PROSTATITIS WITH PSA IN BPH PATIENT
od: Daniel Mahendra Krisna, et al.
Izdano: (2018-07-01)

Autopsy prostate cancer: Pre and post PSA era
od: R Kumar, et al.
Izdano: (2006-01-01)

Role of hK2, free PSA, and complexed PSA measurements in the very early detection of prostate cancer.
od: Lilja, H
Izdano: (2001)

Clinical application of p2PSA and its derivatives (%p2PSA and Phi) in the diagnosis of prostate cancer
od: Weiwang Cai, et al.
Izdano: (2023-11-01)

The effect on the sensitivities of PSA and PSA-age volume score of IPSS and nocturia in predicting positive prostate biopsy findings
od: O. Üçer, et al.
Izdano: (2017-06-01)

Proteolytic activity of prostate-specific antigen (PSA) towards protein substrates and effect of peptides stimulating PSA activity.
od: Johanna M Mattsson, et al.
Izdano: (2014-01-01)

Histopathological findings in extended prostate biopsy with PSA ≤ 4 ng/mL
od: Katia R. Leite, et al.
Izdano: (2008-06-01)